0001209191-21-021781.txt : 20210318 0001209191-21-021781.hdr.sgml : 20210318 20210318165243 ACCESSION NUMBER: 0001209191-21-021781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210317 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JONKER JEFFREY DAVID CENTRAL INDEX KEY: 0001589394 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39512 FILM NUMBER: 21754989 MAIL ADDRESS: STREET 1: C/O NGM BIOPHARMACEUTICALS, INC. STREET 2: 333 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Metacrine, Inc. CENTRAL INDEX KEY: 0001634379 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472297384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-369-7800 MAIL ADDRESS: STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-17 0 0001634379 Metacrine, Inc. MTCR 0001589394 JONKER JEFFREY DAVID C/O METACRINE, INC. 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 8.04 2021-03-17 4 A 0 33000 0.00 A 2031-03-16 Common Stock 33000 33000 D The shares subject to the stock option shall vest in 36 equal monthly installments from the Vesting Commencement Date of March 17, 2021, subject to Reporting Person providing continuous service through such date. /s/ Catherine C. Lee, Attorney-in-fact 2021-03-18